देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
Paracetamol; Codeine phosphate
Sanofi-Aventis Australia Pty Ltd
Medicine Registered
Comfarol Forte CMI CMIv4 GLUv1 GLUv2 Jul12 Page 1 _ _ COMFAROL FORTE TABLETS _PARACETAMOL & CODEINE PHOSPHATE _ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Comfarol Forte tablets. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Comfarol Forte against the benefits this medicine is expected to have for you. KEEP THIS INFORMATION WITH THE TABLETS. You may need to read it again. WHAT IS COMFAROL FORTE USED FOR Comfarol Forte is used to relieve moderate to severe pain and fever. Comfarol Forte contains paracetamol and codeine. Paracetamol and codeine work together to stop the pain messages from getting through to the brain. Paracetamol also acts in the brain to reduce fever. Your doctor may have prescribed this medicine for another use. ASK YOUR DOCTOR OR PHARMACIST IF YOU HAVE ANY QUESTIONS ABOUT WHY THE MEDICINE HAS BEEN PRESCRIBED FOR YOU. This medicine is only available with a doctor’s prescription. BEFORE YOU TAKE COMFAROL FORTE _WHEN YOU MUST NOT TAKE _ _IT _ DO NOT TAKE COMFAROL FORTE IF YOU ARE ALLERGIC TO PARACETAMOL OR CODEINE OR ANY OF THE INGREDIENTS LISTED UNDER “PRODUCT DESCRIPTION” AT THE END OF THIS LEAFLET. The symptoms of an allergic reaction may include a rash, asthma attack or hay fever. DO NOT TAKE THIS MEDICINE IF YOU HAVE OR HAVE HAD ANY OF THE FOLLOWING MEDICAL CONDITIONS: ACUTE BREATHING DIFFICULTIES SUCH AS BRONCHITIS, UNSTABLE ASTHMA OR EMPHYSEMA GLUCOSE-6-PHOSPHATE- DEHYDROGENASE DEFICIENCY (AN ENZYME DEFICIENCY) DIARRHOEA CAUSED BY ANTIBIOTICS OR POISONING DO NOT TAKE COMFAROL FORTE IF YOU HAVE A पूरा दस्तावेज़ पढ़ें
PRODUCT INFORMATION COMFAROL FORTE NAME OF THE MEDICINE NON-PROPRIETARY NAME Paracetamol and codeine phosphate DESCRIPTION Each capsule-shaped tablet contains Paracetamol 500 mg, Codeine phosphate 30 mg. Other ingredients are maize starch, povidone, potassium sorbate, microcrystalline cellulose, stearic acid, magnesium stearate, purified talc, pregelatinised maize starch, and croscarmellose sodium. CAS - 103-90-2 (paracetamol). CAS 41444-62-6 (codeine phosphate hemihydrate) O H NH CH 3 O O OH H N CH 3 H H 3 CO .H 3 PO 4 . 1/2 H 2 0 paracetamol MW 151.17 codeine phosphate MW 406.37 PHARMACOLOGY Analgesic and antipyretic: There is evidence to suggest that a combination of paracetamol with codeine is superior in analgesic action to either drug administered alone. Absorption After oral administration, paracetamol is absorbed rapidly and completely from the small intestine; peak plasma levels occur 30 to 120 minutes after administration. Food intake delays paracetamol absorption. Codeine has about one-sixth of morphine's analgesic activity. It is well absorbed from the gastrointestinal tract and does not interfere with paracetamol absorption. Distribution Paracetamol is uniformly distributed throughout most body fluids; the apparent volume of distribution is 1 to 1.2 L/kg. Paracetamol can cross the placenta and is excreted in milk. Plasma protein binding is negligible at usual therapeutic concentrations but increases with increasing concentrations. Metabolism Paracetamol is metabolised by the hepatic microsomal enzyme system. In adults at therapeutic doses, paracetamol is mainly conjugated with glucuronide (45-55%) or sulfate (20-30%). A minor proportion (less than 20%) is metabolised to catechol derivatives, and mercapturic acid compounds via oxidation. Paracetamol is metabolised differently by infants and children compared to adults, the sulfate conjugate being predom पूरा दस्तावेज़ पढ़ें